Video | TCTAP 2024
[TCTAP Workshops] Antithrombotic Hot Issues in ACS/PCI: What Are New in 2024?
April 25, 2024 / 3:40 PM ~ 4:45 PM 📌 Presentation Room 1, Level 1
Moderator(s):
David Joel Cohen, Tullio Palmerini
Panelist(s):
Sung-Jin Hong, Young-Hoon Jeong, Hyo-Soo Kim, Feng Yu Kuo, Azhari Rosman, Kin Lam Tsui, Hiroyoshi Yokoi
- Contemporary Best Antiplatelet Strategy in HBR or CHIP Patients: How and What?
David Joel Cohen
- When to Escalate or De-Escalate in ACS/PCI
Tullio Palmerini
- Long-Term Antiplatelet Management Beyond 1-Year Post-ACS or Post-PCI
Hyo-Soo Kim
- DAPT Duration in Complex PCI: Unsettled or Already Established Issues?
Duk-Woo Park
- What Are Novel and Future Antithrombotic Drugs in ACS and PCI? Are There Still Unmet Needs?
Roxana Mehran
- Panel Discussion
Panelist(s): Sung-Jin Hong, Young-Hoon Jeong, Hyo-Soo Kim, Feng Yu Kuo, Azhari Rosman, Kin Lam Tsui, Hiroyoshi Yokoi
- Contemporary Best Antiplatelet Strategy in HBR or CHIP Patients: How and What?
David Joel Cohen - When to Escalate or De-Escalate in ACS/PCI
Tullio Palmerini - Long-Term Antiplatelet Management Beyond 1-Year Post-ACS or Post-PCI
Hyo-Soo Kim - DAPT Duration in Complex PCI: Unsettled or Already Established Issues?
Duk-Woo Park - What Are Novel and Future Antithrombotic Drugs in ACS and PCI? Are There Still Unmet Needs?
Roxana Mehran - Panel Discussion
Leave a comment